Exhibit 1

CUSIP No.: 922107107

Joint Filing Statement

Pursuant to Rule 13d-1(k)(1)

The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, par value $0.001 per share of Vapotherm, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.

This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.

Dated: February 14, 2024
	Crow’s Nest Holdings LP
	By:	Crow’s Nest Holdings GP LLC, its General partner
	By:	/s/ John A. Carrington
		John A. Carrington, Managing Member
	Crow’s Nest Holdings Master Fund LP
	By:	Crow’s Nest Holdings LP, its Investment Manager
	By:	Crow’s Nest Holdings GP LLC, the General Partner of the Investment Manager
	By:	/s/ John A. Carrington
		John A. Carrington, Managing Member
	Crow’s Nest GP LLC
	By:	/s/ John A. Carrington
		John A. Carrington, Managing Member
	John A. Carrington
	By:	/s/ John A. Carrington
		John A. Carrington, Individually